Check if your research matches the topics covered in Cancer Biotherapy and Radiopharmaceuticals?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Indexed in the following public directories
Overview | |
Publisher | MARY ANN LIEBERT, INC |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 1996 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
2.3K articles received 27.6K citationssee all
Cancer Biotherapy and Radiopharmaceuticals has been in operation since 1996 till date.
Cancer Biotherapy and Radiopharmaceuticals published with a Monthly frequency.
In 2023, Cancer Biotherapy and Radiopharmaceuticals publsihed 35 articles.
For Cancer Biotherapy and Radiopharmaceuticals, eISSN is 1557-8852 and pISSN is 1084-9785.
Citescore for Cancer Biotherapy and Radiopharmaceuticals is 5.2.
H Index for Cancer Biotherapy and Radiopharmaceuticals is 66.
SNIP score for Cancer Biotherapy and Radiopharmaceuticals is 0.71.
SJR for Cancer Biotherapy and Radiopharmaceuticals is Q2.
MARY ANN LIEBERT, INC is the publisher of Cancer Biotherapy and Radiopharmaceuticals.